News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Omeros names chief accounting officer from within
Omeros Corp., a biopharmaceutical company based in Seattle, recently named David Borges their new chief accounting officer. Borges, who joined Omeros in June 2020, has
Clay Siegall-led biotech inks lease for Bothell headquarters
Immunome Inc., a biotechnology company specializing in targeted cancer therapies, recently signed a lease to move into the headquarters at Bothell’s Alloy Innovation Center. Totaled
Cancer-fighting biotech startup InduPro raises $85M round
InduPro Inc., a biotechnology company dual- headquartered in Seattle and Cambridge, Massachusetts, recently announced its success in raising $85 million in Series A round funding.
Lundbeck to Present a Breadth of Migraine and Cluster Headache Data at the 66th Annual Scientific Meeting of the American Headache Society
Lundbeck, a biopharmaceutical company based in Bothell, Washington, recently shared its positive findings on VYEPTI, their new prescription medicine for treating migraines in adults. New
Jubilant HollisterStier growth pushes to lead Spokane
Jubilant HollisterStier, led by CEO and president Chris Preti, is undergoing a significant expansion and projects to become the No. 1 biomanufacturer in Spokane, Washington.
A Day in the Life of a Lundbeck Biologics Formulation Scientist
Greg Barnett did not envision being part of the life science industry when he graduated from Lehigh University with a bachelor’s degree in chemical engineering.
Cyrus Biotech spins out company to expand reach of versatile drug development software
Cyrus Biotechnology, a Seattle-based software-enabled biotechnology startup focused on autoimmune diseases, announced it will be spinning out a new for-profit subsidiary named, Levitate Bio. The
Allen Institute’s cell lines could lead to new drugs for hypertrophic cardiomyopathy
The Allen Institute, a Seattle-based research institute, has introduced new stem cell lines that could help scientists identify personalized treatment approaches for Hypertrophic cardiomyopathy (HCM),
Report: Seattle Area Among Top 25 Fastest-Growing Markets for Life-Sciences Talent
According to CBRE’s third-annual U.S. Life Sciences Talent Trends report, the Seattle area ranks as a top market for life science graduates. The report notes a 15.1%
Microsoft, Providence and UW make use of generative AI for digital cancer diagnosis
Researchers at Microsoft, Providence Health System and the University of Washington have developed a new artificial intelligence model for diagnosing cancer, based on an analysis
Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes
According to data from a recently released late-stage trial, treatment with Bristol Myers Squibb’s immunotherapies, Opdivo and Yervoy, had better outcomes for patients than the
NVIDIA and top VC firms invest in Vilya, a biotech spinout from Seattle’s Institute for Protein Design
Vilya, a biotech startup built from technology developed at the Seattle-based Institute for Protein Design (IPD), announced an expanded $71 million Series A investment round. The